Indrayani Biotech (BOM:526445) Long-Term Capital Lease Obligation : ₹40 Mil (As of Sep. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Indrayani Biotech Long-Term Capital Lease Obligation?

Indrayani Biotech's Long-Term Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹40 Mil.

Indrayani Biotech's quarterly Long-Term Capital Lease Obligation declined from Mar. 2024 (₹41 Mil) to Jun. 2024 (₹0 Mil) but then increased from Jun. 2024 (₹0 Mil) to Sep. 2024 (₹40 Mil).

Indrayani Biotech's annual Long-Term Capital Lease Obligation increased from Mar. 2022 (₹6 Mil) to Mar. 2023 (₹63 Mil) but then declined from Mar. 2023 (₹63 Mil) to Mar. 2024 (₹41 Mil).

Indrayani Biotech Long-Term Capital Lease Obligation Historical Data

The historical data trend for Indrayani Biotech's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indrayani Biotech Long-Term Capital Lease Obligation Chart

Indrayani Biotech Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

5.50

63.16

40.67

Indrayani Biotech Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	-	40.67	-	39.80

Indrayani Biotech (BOM:526445) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Indrayani Biotech Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Indrayani Biotech's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Indrayani Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Indrayani Biotech Ltd (BOM:526445) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Module No. 32-33, Block 1, 3rd Floor, SIDCO Electronic Complex, Thiru-vi-ka Industrial Estate, Guindy, Chennai, TN, IND, 600032

Website

https://www.indrayani.com

Indrayani Biotech Ltd operates in the Tri-segment i.e. Foods & Hospitality, Engineering and Healthcare divisions. The company generates its revenue from the sale of food, beverages, and other items; the Sale of Engineering products & Others. The majority of its revenue is generated from the sale of food, beverages, and other items.

Indrayani Biotech Headlines

No Headlines